Novab, Inc.
Tucker, GA
- UEI
- WKYDVLA9B616
- CAGE
- 70PZ4
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1860 Montreal Rd, Tucker, GA 30084, USA
- Website
- novabinc.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Novab, Inc. is a for-profit corporate entity that has received several federal grant awards from agencies like the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences, which are part of the Department of Health and Human Services and the National Institutes of Health. The company appears to specialize in developing novel therapeutic and diagnostic products, particularly in the areas of oncology and infectious diseases.
Some key projects funded through federal grants include the development of a novel Chimeric Antigen Receptor T-cell (CAR-T) therapy targeting a unique form of the CD38 antigen for the treatment of multiple myeloma, supported by the National Cancer Institute's Cancer Treatment Research program. Another grant from the National Institute of Allergy and Infectious Diseases focused on creating antibody polymer reagents for highly sensitive and specific detection of SARS-CoV-2 antigens, with potential applications in rapid COVID-19 diagnostic testing. Novab has also received funding from the National Institute of General Medical Sciences to develop monoclonal antibodies specific for biologically relevant glycans. The company's work leverages its expertise in a novel class of antibodies called Variable Lymphocyte Receptors (VLRs), derived from jawless vertebrates like lampreys and hagfish, which offer distinct binding properties compared to conventional antibodies.
Quick answers
Is Novab, Inc. registered in SAM.gov?
Yes. Novab, Inc.'s SAM.gov registration is active through December 3, 2026.
What is Novab, Inc.'s most recent federal award?
Novab, Inc.'s most recent federal grant award is Novel targeted car-t multiple myeloma therapy (R43CA287584), from National Cancer Institute (NIH), on September 19, 2023.
On GovTribe
See Novab, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors